Short description:
Rare Muscle Disorders
Drug notes:
Also Clin2 myelofibrosis; KER-047 Clin2 iron deficiency anemia, Clin1 iron deficiency anemia in MDS & MF; KER-012 Clin1PAH; undisclosed Clin0 musculoskeletal conditions
Long description:
Keros Therapeutics is discovering and developing treatments for rare hematologic and musculoskeletal disorders. A wide range of disorders are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-β). At Keros, they are using their protein engineering and drug development expertise to uncover targets within the TGF-β superfamily. By developing therapeutics that can intervene in this pathway, Keros aims to target pathways critical for the growth, repair and maintenance of blood cells and a number of tissues including bone, skeletal muscle, adipose and heart tissue.
Jobs:
Associate Director, Project Management Lexington, MA|16 days ago
Executive Director/Vice President, Analytical Deve... Lexington, MA|16 days ago
Regulatory Affairs Associate Lexington, MA|18 days ago
Director, Clinical Sciences Lexington, MA|18 days ago
Senior Director, Clinical Program Leader Lexington, MA|26 days ago
VP / Executive Medical Director Lexington, MA|29 days ago
Associate Director, Quality Control Lexington, MA|33 days ago
Senior Manager, Quality Operations Lexington, MA|40 days ago
Associate Director, Corporate Communications Lexington, MA|40 days ago
General Application Lexington, Massachusetts, Stati Uniti d'America|79 days ago